In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

The tomato ingredient may inhibit the formation and spread of cancer cells in the prostate, Omar Kucuk, MD, et al., Barbara Ann Karmanos Cancer Institute, preliminarily report at the annual meeting of the American Association for Cancer Research in Philadelphia April 12. Thirty men scheduled for radical prostatectomy received either 15 mg lycopene twice daily or no intervention for three weeks prior to surgery. After surgery, examination of the removed prostates showed cancer had not spread beyond the prostate in 67% of the treated subjects, and 84% had tumors ( 4 cm3 in size, compared to 44% and 55% in the untreated subjects, respectively

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts